Prelude Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,083	Closed	-$7K	–	1414
2019 Q2	$7K	Buy	+1,083	New	+$7K	﹤0.01%	1070
2018 Q3	–	Sell	-1,200	Closed	-$14K	–	1543
2018 Q2	$14K	Buy	+1,200	New	+$14K	﹤0.01%	1146